0001437749-19-010764.txt : 20190523 0001437749-19-010764.hdr.sgml : 20190523 20190523163420 ACCESSION NUMBER: 0001437749-19-010764 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190523 DATE AS OF CHANGE: 20190523 EFFECTIVENESS DATE: 20190523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001757966 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340287 FILM NUMBER: 19850622 BUSINESS ADDRESS: STREET 1: 689 FIFTH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-871-7920 MAIL ADDRESS: STREET 1: 689 FIFTH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001757966 Neogene Therapeutics, Inc. 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 212-871-7920 DELAWARE None None Corporation true 2018 Carsten Linnemann, PhD 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director Promoter David M. Tanen 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Director Promoter Fei Chen 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Director Helen Kim 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Director Antonius N.M. Schumacher 689 Fifth Avenue 12th Floor New York NY NEW YORK 10022 Director Biotechnology Decline to Disclose 06b false 2019-05-10 false true false 0 15000000 15000000 0 false 42 0 0 0 false Neogene Therapeutics, Inc. /s/ David M. Tanen David M. Tanen Corporate Secretary 2019-05-23